Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C038864 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NRL mRNA | increases expression | 16854989
|
C038864 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NRL protein | increases expression | 16854989
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of NRL mRNA | increases expression | 16854989
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of NRL protein | increases expression | 16854989
|
C419708 |
gefitinib |
gefitinib results in decreased expression of NRL mRNA | decreases expression | 16685379
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NRL mRNA | increases expression | 16854989
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NRL protein | increases expression | 16854989
|
D014212 |
Tretinoin |
[Tretinoin binds to RARA protein] which binds to NRL promoter | affects binding | 16854989
|
D014212 |
Tretinoin |
[Tretinoin binds to RXRA protein] which binds to NRL promoter | affects binding | 16854989
|
D014212 |
Tretinoin |
[Tretinoin binds to RXRG protein] which binds to NRL promoter | affects binding | 16854989
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NRL mRNA | increases expression | 16854989
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NRL protein | increases expression | 16854989
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NRL protein | increases expression | 16854989
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.94 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.30 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.33 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.43 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.91 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
4.03 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.47 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.47 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.22 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.88 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.92 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
gefitinib |
4.05 | 16230376 20005069 17290066 18347146 19233551 15496427 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.37 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.30 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.22 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.88 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.80 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.26 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
gefitinib |
3.25 | 17594712 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 9664655 9142499 10589399 14991402 17551590 9211117 9224671 8800419 9125849 16925845 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.19 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.35 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.87 | 9664655 16938888 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
4.07 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.24 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.44 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.88 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.07 | 14991402 9664655 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.53 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.13 | 16778211 |
MESH:D006976 |
Hypertension, Pulmonary |
|
gefitinib |
4.97 | 18424623 |
MESH:D017380 |
Hypertrophy, Right Ventricular |
|
gefitinib |
6.87 | 18424623 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.33 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.33 | 17551590 15992940 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
6.27 | 16144296 |
MESH:D007680 |
Kidney Neoplasms |
|
gefitinib |
4.89 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.93 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.12 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.12 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.39 | 16766008 9834237 17301526 19642359 19029980 17339181 17649720 19075265 19225113 17712046 17217047 19035177 15748426 16140955 16935935 17294898 17506722 16788101 12679006 16823087 16891316 17361223 17368321 17107899 16331271 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.58 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
2.65 | 16413115 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
gefitinib |
4.36 | 18375820 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.91 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.98 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.99 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.28 | 17596541 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
5.95 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.95 | 16946489 16594593 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.28 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.29 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.44 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.24 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.57 | 15976015 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.73 | 16144296 |
MESH:D011471 |
Prostatic Neoplasms |
|
gefitinib |
4.59 | 16685379 15651060 17914592 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.07 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.42 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
gefitinib |
4.12 | 18424623 |
MESH:D012174 |
Retinitis Pigmentosa |
marker/mechanism |
|
| |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.56 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.76 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
gefitinib |
8.75 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
8.75 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.18 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.45 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.07 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.33 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.56 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.34 | 16287080 |